260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA
Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Board Expansion: Robert Iannone and Flavia Borellini Appointed Directors
Pliant Therapeutics 2026 Annual Meeting Results; Directors Elected
Provides Corporate Update and Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Director Retirement - David E.I. Pyott Steps Down from Board
Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
News, Securities Holder Rights or Indentures
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Registration of Securities
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRER14A
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership